132 related articles for article (PubMed ID: 28301899)
1. Thrombosis Prediction Based on Reference Ranges of Coagulation-Related Markers in Different Stages of Pregnancy.
Sekiya A; Hayashi T; Kadohira Y; Shibayama M; Tsuda T; Jin X; Nomoto H; Asakura H; Wada T; Ohtake S; Morishita E
Clin Appl Thromb Hemost; 2017 Oct; 23(7):844-850. PubMed ID: 28301899
[TBL] [Abstract][Full Text] [Related]
2. Fibrin monomer complex in normal pregnant women: a potential thrombotic marker in pregnancy.
Onishi H; Kaniyu K; Iwashita M; Tanaka A; Watanabe T
Ann Clin Biochem; 2007 Sep; 44(Pt 5):449-54. PubMed ID: 17761030
[TBL] [Abstract][Full Text] [Related]
3. [A novel molecular marker for thrombus formation and life prognosis--clinical usefulness of measurement of soluble fibrin monomer-fibrinogen complex (SF)].
Koga S
Rinsho Byori; 2004 Apr; 52(4):355-61. PubMed ID: 15164605
[TBL] [Abstract][Full Text] [Related]
4. Coagulation and fibrinolysis changes in normal pregnancy. Increased levels of procoagulants and reduced levels of inhibitors during pregnancy induce a hypercoagulable state, combined with a reactive fibrinolysis.
Cerneca F; Ricci G; Simeone R; Malisano M; Alberico S; Guaschino S
Eur J Obstet Gynecol Reprod Biol; 1997 May; 73(1):31-6. PubMed ID: 9175686
[TBL] [Abstract][Full Text] [Related]
5. Dysfunctional coagulation and fibrinolysis systems due to adenomyosis is a possible cause of thrombosis and menorrhagia.
Yamanaka A; Kimura F; Yoshida T; Kita N; Takahashi K; Kushima R; Murakmai T
Eur J Obstet Gynecol Reprod Biol; 2016 Sep; 204():99-103. PubMed ID: 27543913
[TBL] [Abstract][Full Text] [Related]
6. [Hypercoagulability during pregnancy: evidences for a thrombophilic state].
Maiello M; Torella M; Caserta L; Caserta R; Sessa M; Tagliaferri A; Bernacchi M; Napolitano M; Nappo C; De Lucia D; Panariello S
Minerva Ginecol; 2006 Oct; 58(5):417-22. PubMed ID: 17006429
[TBL] [Abstract][Full Text] [Related]
7. Challenges in the evaluation of D-dimer and fibrinogen levels in pregnant women.
Réger B; Péterfalvi A; Litter I; Pótó L; Mózes R; Tóth O; Kovács GL; Losonczy H
Thromb Res; 2013 Apr; 131(4):e183-7. PubMed ID: 23481480
[TBL] [Abstract][Full Text] [Related]
8. Comparison of markers of coagulation activation and thrombin generation test in uncomplicated pregnancies.
Joly B; Barbay V; Borg JY; Le Cam-Duchez V
Thromb Res; 2013 Sep; 132(3):386-91. PubMed ID: 23962423
[TBL] [Abstract][Full Text] [Related]
9. Significance of coagulation and fibrinolysis markers for benign and malignant soft tissue tumors.
Asanuma K; Nakamura T; Hagi T; Okamoto T; Kita K; Nakamura K; Matsuyama Y; Yoshida K; Asanuma Y; Sudo A
BMC Cancer; 2021 Apr; 21(1):364. PubMed ID: 33827473
[TBL] [Abstract][Full Text] [Related]
10. Age-based difference in activation markers of coagulation and fibrinolysis in extracorporeal membrane oxygenation.
Hundalani SG; Nguyen KT; Soundar E; Kostousov V; Bomgaars L; Moise A; Hui SK; Teruya J
Pediatr Crit Care Med; 2014 Jun; 15(5):e198-205. PubMed ID: 24614609
[TBL] [Abstract][Full Text] [Related]
11. Endothelial cell markers and fibrinopeptide A to D-dimer ratio as a measure of coagulation and fibrinolysis balance in normal pregnancy.
Bellart J; Gilabert R; Miralles RM; Monasterio J; Cabero L
Gynecol Obstet Invest; 1998; 46(1):17-21. PubMed ID: 9692335
[TBL] [Abstract][Full Text] [Related]
12. Predictive values of coagulation/fibrinolysis parameters for the termination of pregnancy complicated by severe preeclampsia.
Kobayashi T; Tokunaga N; Sugimura M; Kanayama N; Terao T
Semin Thromb Hemost; 2001; 27(2):137-41. PubMed ID: 11372767
[TBL] [Abstract][Full Text] [Related]
13. Haemostatic reference intervals in pregnancy.
Szecsi PB; Jørgensen M; Klajnbard A; Andersen MR; Colov NP; Stender S
Thromb Haemost; 2010 Apr; 103(4):718-27. PubMed ID: 20174768
[TBL] [Abstract][Full Text] [Related]
14. [Haemocoagulative modifications correlated with pregnancy].
Borrelli AL; De Lucia D; Bernacchi M; Napolitano M; Di Domenico A; Felicetti M; Ferrara C; Meo D; Raffio R; Rivetti A; Sessa M; Tagliaferri A; Torella M
Minerva Ginecol; 2006 Aug; 58(4):315-22. PubMed ID: 16957675
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of an optimal dose of low-molecular-weight heparin for thromboprophylaxis in pregnant women at risk of thrombosis using coagulation activation markers.
Bombeli T; Raddatz Mueller P; Fehr J
Haemostasis; 2001; 31(2):90-8. PubMed ID: 11684864
[TBL] [Abstract][Full Text] [Related]
16. Fluctuations in levels of antiphospholipid antibodies and increased coagulation activation markers in normal and heparin-treated antiphospholipid syndrome pregnancies.
Donohoe S; Quenby S; Mackie I; Panal G; Farquharson R; Malia R; Kingdom J; Machin S
Lupus; 2002; 11(1):11-20. PubMed ID: 11898913
[TBL] [Abstract][Full Text] [Related]
17. Reference intervals of D-dimer during the pregnancy and puerperium period on the STA-R evolution coagulation analyzer.
Wang M; Lu S; Li S; Shen F
Clin Chim Acta; 2013 Oct; 425():176-80. PubMed ID: 23954836
[TBL] [Abstract][Full Text] [Related]
18. Coagulation activation markers do not correlate with the clinical risk of thrombosis in pregnant women.
Bombeli T; Raddatz-Mueller P; Fehr J
Am J Obstet Gynecol; 2001 Feb; 184(3):382-9. PubMed ID: 11228491
[TBL] [Abstract][Full Text] [Related]
19. [Diagnosis of thrombosis by hemostatic markers].
Wada H; Matsumoto T; Yamashita Y
Nihon Rinsho; 2014 Jul; 72(7):1232-6. PubMed ID: 25163313
[TBL] [Abstract][Full Text] [Related]
20. [Pre- and postpartum hemostatic characteristics in pregnancy-related hypertension and pre-eclampsia in comparison with normotensive pregnancies].
Hofmann M; Casper F; Prellwitz W; Brockerhoff P
Z Geburtshilfe Neonatol; 1996; 200(3):104-8. PubMed ID: 8963881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
